Peptide and wellness research, graded on the strength of its evidence and written in plain language.
Evidence before hype
Every compound shows its evidence grade and regulatory status.
Plainly reported, fully sourced, and clear about how much the evidence really supports.
Incretin drugs produced some of the largest weight-loss results in trial history. Understanding what those trials measured — and what they did not — is the difference between literacy and enthusiasm.
A rat tendon is not a human tendon. The most common error in peptide discussion is treating an animal result as a human conclusion.
Before any compound enters the conversation, the interventions with the strongest recovery evidence are unglamorous and free.
Every compound in the library carries a grade from A to E. Here is exactly what each grade means and how it is assigned.
Weight change is the headline. The trials that measured cardiovascular events and kidney progression are the more consequential literature — and they are read far less often.
Scales measure mass, not tissue. When weight falls quickly, some of what leaves is muscle and bone — and the research on preserving it is thinner than the research on losing weight.
Every compound gets a grade from A to E for how much is known about it in humans — not how promising it sounds. Each page explains its grade.
How grading worksMultiple randomised controlled trials in humans, typically supporting an approved indication.
Several human trials exist, but they are limited in size, duration or consistency.
Small, early-phase or single-centre human studies only. Findings are preliminary.
Animal and laboratory research only. No meaningful published human data.
Very little published research of any kind. Discussion is largely theoretical or anecdotal.
A long-acting GLP-1 receptor agonist and the most heavily studied peptide in modern metabolic medicine.
An investigational triple incretin agonist that produced very large weight reductions in phase 2 research.
The most discussed recovery peptide in wellness culture, and one of the clearest examples of a preclinical evidence base being read as clinical proof.
Why people actually use these peptides — weight loss and liver fat, skin and hair, injury recovery — each case study graded on what the research supports.
The most common reason people look at peptides at all: sustained appetite reduction, and what trials report about liver fat alongside it.
Evidence grade BSkin & HairThe KLOW and GLOW stacks are the most-discussed cosmetic peptide combinations. Here is what each ingredient actually has behind it.
Evidence grade DRecoveryBPC-157 is the single most searched research peptide. The gap between how confidently it is discussed and what has been published in humans is the story here.
Evidence grade DShort explainers, from what a peptide is to how to read a single study.
Turn vial amount and diluent volume into concentration, aliquot volume and aliquots per vial. Every unit labelled, nothing rounded away.